Exam 2026/2027 | Advanced
Pharmacology for Care of the Family |
Questions & Answers | Grade A | Pass
Guaranteed - A+ Graded
General Principles of Advanced Pharmacology & Special Populations
Q1: [DATA SNIPPET] Review the following patient data: Age: 78, Weight: 60 kg, Serum
Creatinine: 2.2 mg/dL (stable). Estimated Creatinine Clearance: ~26 mL/min. The
patient requires treatment for a skin infection. Which of the following antibiotics requires
a dosage adjustment or is contraindicated in this patient?
A. Doxycycline
B. Cephalexin
C. Levofloxacin [CORRECT]
D. Azithromycin
Correct Answer: C
Rationale: Levofloxacin is primarily excreted renally and requires significant dosage
adjustment when creatinine clearance is less than 50 mL/min; in contrast, the other
options listed do not require routine adjustment for this level of renal impairment.
Q2: When prescribing for a pediatric patient, what is the primary physiological difference
that necessitates weight-based dosing rather than fixed adult dosing?
A. Pediatric patients have slower gastric emptying times.
B. Children have a higher percentage of total body water and faster metabolic rates.
[CORRECT]
C. Pediatric livers are fully mature by age 2.
D. Children cannot absorb enteric-coated tablets.
Correct Answer: B
Rationale: Children generally have a higher volume of total body water and a higher
metabolic rate relative to adults, meaning water-soluble drugs distribute differently and
may require higher mg/kg doses.
,Q3: A 30-year-old female patient who is breastfeeding asks about the safety of using
over-the-counter antihistamines. What is the primary pharmacokinetic factor
determining drug excretion into breast milk?
A. The drug's molecular weight and lipid solubility. [CORRECT]
B. The drug's protein binding to albumin.
C. The pH of the infant's stomach.
D. The route of administration of the drug.
Correct Answer: A
Rationale: Drugs that are lipid-soluble and have lower molecular weights cross
biological membranes more easily and are therefore more likely to pass into breast milk.
Q4: A patient with liver failure requires a medication that is highly protein-bound. What
is the expected impact of hypoalbuminemia on the drug's pharmacodynamics?
A. The free fraction of the drug decreases, reducing efficacy.
B. The free fraction of the drug increases, raising the risk of toxicity. [CORRECT]
C. The drug is metabolized faster by the liver.
D. The drug is excreted unchanged by the kidneys.
Correct Answer: B
Rationale: In hypoalbuminemia, fewer proteins are available for binding, which leads to
a higher concentration of free (active) drug that can cause toxicity even at standard
doses.
Q5: When evaluating a new medication for a pregnant patient in her first trimester, the
prescriber checks the FDA pregnancy category. Which category indicates that adequate
studies have failed to demonstrate a risk to the fetus, but the possibility of harm cannot
be ruled out?
A. Category A
B. Category B [CORRECT]
C. Category C
D. Category D
Correct Answer: B
Rationale: Category B is defined by animal reproduction studies failing to demonstrate a
risk to the fetus, but there are no adequate and well-controlled studies in pregnant
women.
Q6: The "First Pass Effect" significantly impacts the bioavailability of which route of
administration?
A. Intravenous (IV)
B. Sublingual
C. Oral (PO) [CORRECT]
D. Transdermal
, Correct Answer: C
Rationale: Oral medications pass through the liver via the portal vein before entering
systemic circulation, where they may be metabolized, reducing the amount of active
drug that reaches the blood.
Q7: A geriatric patient is prescribed a drug with a narrow therapeutic index. To minimize
the risk of adverse drug reactions (ADRs), the prescriber should follow which geriatric
prescribing principle?
A. "Start high and go slow" to ensure efficacy.
B. "Start low and go slow" and monitor frequently. [CORRECT]
C. Avoid using generic medications.
D. Prescribe the maximum adult dose to compensate for absorption issues.
Correct Answer: B
Rationale: Older adults often have reduced renal and hepatic function; starting low and
titrating slowly minimizes the risk of accumulation and toxicity.
Q8: Which phase of clinical trials involves testing a new drug on a small group of
healthy volunteers to determine safety and pharmacokinetics?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Correct Answer: A
Rationale: Phase I trials focus on safety, dosage, and pharmacokinetics in a small,
healthy population before testing for efficacy in larger patient groups.
Q9: A patient taking a drug that is a CYP450 enzyme inhibitor starts taking a second
drug metabolized by the same enzyme. What is the likely pharmacokinetic outcome?
A. The metabolism of the second drug is decreased, leading to increased plasma levels.
[CORRECT]
B. The metabolism of the second drug is increased, leading to decreased plasma levels.
C. The two drugs will cancel each other out.
D. The half-life of the first drug will decrease.
Correct Answer: A
Rationale: An inhibitor slows down the enzyme responsible for metabolism, causing the
substrate drug to accumulate in the body to potentially toxic levels.
Q10: When calculating pediatric maintenance fluids using the Holliday-Segar method,
what is the primary factor determining the fluid rate?
A. The child's weight in kilograms. [CORRECT]
B. The child's height.